Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01481428 · ClinicalTrials.gov registry record · Phase 1
Reducing High Risk Behavior in Treatment Court
A Phase 1 study, sponsored by Treatment Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 371
- Enrollment target
NCT01481428: Completed Phase 1 study, sponsored by Treatment Research Institute.
NCT01481428 is a Phase 1 study that has completed, run by Treatment Research Institute. The registered enrollment target is 371 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (518% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01481428, a Phase 1 study, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 371 participants
- Enrollment target
Study Summary
This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.
Primary Outcome
Measured by the Risk Assessment Battery (RAB)
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Computer-facilitated HIV intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT01481428 record still lists
NCT01481428 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (518% higher).
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT01481428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01481428 about?
NCT01481428 is a clinical study titled "Reducing High Risk Behavior in Treatment Court". This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.
What is the current status of trial NCT01481428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 371 participants. The study started on 2012-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01481428?
The interventions under investigation include: Attention Control (BEHAVIORAL), Computer-facilitated HIV intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01481428?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01481428's enrollment target sits among peer trials
371 86th of 2000 higher than 1,915 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia